Literature DB >> 32318860

MUW researcher of the month.

Henrike Arfsten1.   

Abstract

Mesh：

Year:  2020        PMID： 32318860     DOI： 10.1007/s00508-020-01656-3

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN： 0043-5325            Impact factor:   1.704


× No keyword cloud information.
  9 in total

1.  A Unifying Concept for the Quantitative Assessment of Secondary Mitral Regurgitation.

Authors:  Philipp E Bartko; Henrike Arfsten; Gregor Heitzinger; Noemi Pavo; Aurel Toma; Guido Strunk; Christian Hengstenberg; Martin Hülsmann; Georg Goliasch
Journal:  J Am Coll Cardiol       Date:  2019-05-28       Impact factor: 24.094

2.  Prescription Bias in the Treatment of Chronic Systolic Heart Failure.

Authors:  Henrike Arfsten; Georg Goliasch; Noemi Pavo; Hanno Ulmer; Martin Hülsmann; Thomas Stefenelli
Journal:  Ann Intern Med       Date:  2019-10-01       Impact factor: 25.391

3.  PONTIAC (NT-proBNP selected prevention of cardiac events in a population of diabetic patients without a history of cardiac disease): a prospective randomized controlled trial.

Authors:  Martin Huelsmann; Stephanie Neuhold; Michael Resl; Guido Strunk; Helmut Brath; Claudia Francesconi; Christopher Adlbrecht; Rudolf Prager; Anton Luger; Richard Pacher; Martin Clodi
Journal:  J Am Coll Cardiol       Date:  2013-06-27       Impact factor: 24.094

4.  Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry.

Authors:  Aldo P Maggioni; Stefan D Anker; Ulf Dahlström; Gerasimos Filippatos; Piotr Ponikowski; Faiez Zannad; Offer Amir; Ovidiu Chioncel; Marisa Crespo Leiro; Jaroslaw Drozdz; Andrejs Erglis; Emir Fazlibegovic; Candida Fonseca; Friedrich Fruhwald; Plamen Gatzov; Eva Goncalvesova; Mahmoud Hassanein; Jaromir Hradec; Ausra Kavoliuniene; Mitja Lainscak; Damien Logeart; Bela Merkely; Marco Metra; Hans Persson; Petar Seferovic; Ahmet Temizhan; Dimitris Tousoulis; Luigi Tavazzi
Journal:  Eur J Heart Fail       Date:  2013-08-26       Impact factor: 15.534

5.  Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction.

Authors:  Stephen J Greene; Gregg C Fonarow; Adam D DeVore; Puza P Sharma; Muthiah Vaduganathan; Nancy M Albert; Carol I Duffy; C Larry Hill; Kevin McCague; J Herbert Patterson; John A Spertus; Laine Thomas; Fredonia B Williams; Adrian F Hernandez; Javed Butler
Journal:  J Am Coll Cardiol       Date:  2019-03-04       Impact factor: 24.094

6.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Authors:  Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer
Journal:  Eur Heart J       Date:  2016-05-20       Impact factor: 29.983

7.  Increased granulocyte membrane neprilysin (CD10) expression is associated with better prognosis in heart failure.

Authors:  Noemi Pavo; Alfred Gugerell; Georg Goliasch; Philipp Emanuel Bartko; Henrike Arfsten; Johannes Franz Novak; Mariann Gyöngyösi; Martin Hülsmann
Journal:  Eur J Heart Fail       Date:  2019-03-03       Impact factor: 15.534

8.  Phenotyping progression of secondary mitral regurgitation in chronic systolic heart failure.

Authors:  Henrike Arfsten; Philipp E Bartko; Noemi Pavo; Gregor Heitzinger; Julia Mascherbauer; Christian Hengstenberg; Martin Hülsmann; Georg Goliasch
Journal:  Eur J Clin Invest       Date:  2019-10-09       Impact factor: 4.686

9.  Parameters associated with therapeutic response using peritoneal dialysis for therapy refractory heart failure and congestive right ventricular dysfunction.

Authors:  Noemi Pavo; Rajashri Yarragudi; Heidi Puttinger; Henrike Arfsten; Guido Strunk; Andja Bojic; Martin Hülsmann; Andreas Vychytil
Journal:  PLoS One       Date:  2018-11-19       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.